(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEMA RESEARCH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEMA RESEARCH

ST13

US500000090638945

Class

35, 42

Filing

90638945

Registration

6678676

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

8

Latest update

03/22/2022

Trademark type

Word

Nice classes

35, 42

Filing date

04/12/2021

Registration date

03/22/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/22/2022

Last transaction

03/22/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

07/28/1997

First use in commerce

07/28/1997

Drawing code

4

Owner type

03

Owner location

Naples, FL, US

Examiner

MCPHERSON RAYBURN, SHAVELL A

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NEMA RESEARCH INC.

Representatives

MATTHEW P. HINTZ, ESQ. LOWENSTEIN SANDLER LLP

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Business consulting and management in the field of clinical trials and decentralized clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceuticalbiotechnology companies to assist them with clinical researchmarket aligned planningclinical trialsdecentralized clinical trialsapplications for drug approval

Class 42

Medical and scientific researchconducting clinical trials and decentralized clinical trials for others; Providing medical and scientific research information in the field of clinical trials and decentralized clinical trials; Research and development in the field of protocol development for clinical research studies and decentralized clinical trials; Consulting services for others in the field of designplanningimplementation project management of scientific researchclinical trials and decentralized clinical trials; Quality management servicesperforming corrective and preventive actions (CAPA) in the field of clinical trials and decentralized clinical trials; Clinical research organization (CRO) servicesconducting clinical trialsdecentralized clinical trials

Publications

History of USPTO decisions and trademark events.

8 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

03/22/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/04/2022

PUBO

PUBLISHED FOR OPPOSITION

01/04/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/15/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2021

DOCK

ASSIGNED TO EXAMINER

12/01/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/19/2021

NWAP

NEW APPLICATION ENTERED

04/15/2021

Continuous trademark protection

Get notified about every new filing that threatens NEMA RESEARCH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.